Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,891 | 108,005 | 184,434 | 143,583 | 221,804 |
| Marketable Securities | 292,735 | 268,391 | 183,355 | 171,910 | 36,900 |
| Receivables | N/A | 1,410 | 10,255 | 846 | 661 |
| Other current assets | 7,082 | 20,204 | 2,191 | 1,782 | 2,563 |
| TOTAL | $419,521 | $405,299 | $384,597 | $322,372 | $265,247 |
| Non-Current Assets | |||||
| PPE Net | 290,262 | 110,297 | 48,675 | 30,881 | 23,215 |
| Investments And Advances | 0 | 105,872 | 245,595 | 137,487 | 44,176 |
| Intangibles | 10,262 | 11,962 | 13,663 | 15,363 | 17,064 |
| Other Non-Current Assets | 45,507 | 58,509 | 17,618 | 16,401 | 144 |
| TOTAL | $346,031 | $286,640 | $325,551 | $200,132 | $84,599 |
| Total Assets | $765,552 | $691,939 | $710,148 | $522,504 | $349,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 35,866 | 2,868 | 9,457 | 6,829 | 7,650 |
| Accrued Expenses | 57,726 | 59,107 | 23,774 | 13,450 | 11,461 |
| Other current liabilities | 435 | N/A | N/A | 17 | 17 |
| TOTAL | $105,456 | $138,850 | $146,536 | $40,682 | $97,071 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 866 | 74,099 | 111,055 | 19,291 | 77,944 |
| Other Non-Current Liabilities | 376,934 | 79,231 | 23,295 | 20,043 | 0 |
| TOTAL | $372,934 | $134,750 | $154,790 | $20,043 | $8,739 |
| Total Liabilities | $478,390 | $273,600 | $301,326 | $60,725 | $105,809 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 107,432 | 106,006 | 104,526 | 102,757 | 95,708 |
| Common Shares | 200 | 198 | 197 | 195 | 188 |
| Retained earnings | -1,026,030 | -820,755 | -644,692 | -503,844 | -419,291 |
| Other shareholders' equity | 12,597 | 19,683 | -69 | 18 | -947 |
| TOTAL | $287,162 | $418,339 | $408,822 | $461,779 | $244,036 |
| Total Liabilities And Equity | $765,552 | $691,939 | $710,148 | $522,504 | $349,846 |